title: Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome.
abstract: Dermal fibroblasts from nine Marfan syndrome patients with missense mutations in the fibrillin-1 gene (FBN1) produced nearly normal amounts of fibrillin as determined by quantitative pulse-chase experiments. However, six of the seven mutations involving substitutions of highly conserved cysteine residues exhibited lower rates of intracellular transport and secretion. This effect is likely due to improper folding, since intracellular fibrillin processing was also affected by the reducing agent dithiothreitol. Normal secretion patterns were seen in three mutations that either change the conformation of EGF-like domains or change consensus amino acids required for Ca(++)-binding. In all nine fibroblasts strains, however, the deposition of fibrillin in the extracellular matrix was reduced to 50% of normal in two and to less than 30% in seven of the nine samples studied. The protein alterations caused by these missense mutations are associated with moderate to severe features of Marfan syndrome and a dominant negative mechanism is suggested to play a major role in their pathogenesis.
authors.affiliation: Department of Pathology, Howard Hughes Medical Institute, Stanford, CA.
authors.forename: T
authors.initials: T
authors.lastname: Aoyama
authors.forename: K
authors.initials: K
authors.lastname: Tynan
authors.forename: H C
authors.initials: HC
authors.lastname: Dietz
authors.forename: U
authors.initials: U
authors.lastname: Francke
authors.forename: H
authors.initials: H
authors.lastname: Furthmayr
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites; D002417:Cattle; D002478:Cells, Cultured; D017124:Conserved Sequence; D004815:Epidermal Growth Factor / Q000235:genetics; D005170:Factor X / Q000235:genetics; D005260:Female; D000071838:Fibrillin-1; D000071837:Fibrillins; D005347:Fibroblasts / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008297:Male; D008382:Marfan Syndrome / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D008840:Microfilament Proteins / Q000096:biosynthesis* / Q000737:chemistry / Q000235:genetics*; D008969:Molecular Sequence Data; D010641:Phenotype; D017354:Point Mutation; D017510:Protein Folding; D011499:Protein Processing, Post-Translational; D017433:Protein Structure, Secondary; D012016:Reference Values; D017386:Sequence Homology, Amino Acid; D012867:Skin / Q000378:metabolism / Q000473:pathology; D054392:Adipokines
chemical_list: D004815:Epidermal Growth Factor; D005170:Factor X; D000071838:Fibrillin-1; D000071837:Fibrillins; D008840:Microfilament Proteins; C000605722:FBN1 protein, human; D054392:Adipokines